Oxidative phosphorylation as a potential therapeutic target for cancer therapy

Area of Science:

• Biochemistry
• Cancer Biology
• Metabolic Pathways

Background:

• Contrary to previous assumptions, cancer cells depend on oxidative phosphorylation (OXPHOS) for survival and proliferation.
• Increased reliance on OXPHOS is a hallmark of cancer stem cells and is linked to resistance against chemotherapy and tyrosine kinase inhibitors.

Purpose of the Study:

• To investigate the role of oxidative phosphorylation (OXPHOS) in cancer cell survival and therapeutic resistance.
• To explore the potential of OXPHOS inhibitors as a therapeutic strategy for cancer treatment, particularly in combination regimens.

Main Methods:

• Review of preclinical data on OXPHOS inhibitors in cancer treatment.
• Analysis of therapeutic strategies targeting mitochondrial function, including inhibiting mitochondrial biogenesis and respiratory chain complexes.
• Examination of combination therapies involving OXPHOS inhibitors, tyrosine kinase inhibitors, and glycolysis inhibitors.

Main Results:

• Cancer cells, particularly cancer stem cells, exhibit a significant dependency on OXPHOS.
• OXPHOS inhibition presents a viable therapeutic avenue, especially when combined with other anti-cancer agents to induce an energy crisis.
• Current preclinical evidence largely stems from xenograft models, highlighting a need for further investigation.

Conclusions:

• Targeting oxidative phosphorylation (OXPHOS) is a promising strategy for cancer therapy, especially in combination treatments.
• Future research should focus on optimizing treatment schedules and combination regimens for OXPHOS inhibitors that are compatible with anti-cancer immune responses for sustained tumor control.
• Further studies are needed to validate these findings in models that better reflect the tumor microenvironment and immune interactions.